https://www.selleckchem.com/pr....oducts/jbj-09-063-hy
were also needed to be formulated based on the prognostic factors in order to improve the prognosis of patients.Objective This study was to investigate the perioperative safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei (PMP), and analyze the risk factors of serious adverse events (SAEs). Methods The occurrences of perioperative SAEs were retrospectively analyzed in 254 PMP patients treated with CRS plus HIPEC. Univariate and multivariate analysis wer
Me gusta
Comentario
Compartir
